United Therapeutics
UTHR
UTHR
373 hedge funds and large institutions have $4.76B invested in United Therapeutics in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 143 increasing their positions, 126 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
373
Holders Change
–
Holders Change %
0%
% of All Funds
8.55%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
31
Increased
143
Reduced
126
Closed
29
Calls
$35.1M
Puts
$25.4M
Net Calls
+$9.71M
Net Calls Change
+$10.2M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$30.6M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$20.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$19.2M |
| 4 |
BlackRock
New York
|
+$13M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$43.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.1M |
| 3 |
JPMorgan Chase & Co
New York
|
-$29.6M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$20.3M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$19.4M |
